| scholarly article | Q13442814 |
| P2093 | author name string | Yan Xie | |
| Jianyang Luo | |||
| Nicholas O Davidson | |||
| Susan M Kennedy | |||
| Elizabeth P Newberry | |||
| P2860 | cites work | Effect of branched-chain fatty acid on lipid dynamics in mice lacking liver fatty acid binding protein gene | Q45251473 |
| Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein | Q45293298 | ||
| A new transgenic rat model of hepatic steatosis and the metabolic syndrome | Q46421393 | ||
| A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes | Q46626385 | ||
| Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance | Q46774694 | ||
| Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver | Q46818626 | ||
| Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency. | Q46851248 | ||
| Adaptations to the loss of intestinal fatty acid binding protein in mice | Q46987404 | ||
| Ablation of the Liver Fatty Acid Binding Protein Gene Decreases Fatty Acyl CoA Binding Capacity and Alters Fatty Acyl CoA Pool Distribution in Mouse Liver | Q47597742 | ||
| The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. | Q52541214 | ||
| Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. | Q54076811 | ||
| Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade | Q77795070 | ||
| Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting | Q24563197 | ||
| Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance | Q24629603 | ||
| A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders | Q28116120 | ||
| Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene | Q28138952 | ||
| Decreased Hepatic Triglyceride Accumulation and Altered Fatty Acid Uptake in Mice with Deletion of the Liver Fatty Acid-binding Protein Gene | Q28208142 | ||
| Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes | Q28264518 | ||
| The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism | Q28292765 | ||
| The binding of cholesterol and bile salts to recombinant rat liver fatty acid-binding protein | Q28301827 | ||
| Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha) | Q28509440 | ||
| Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage | Q28511072 | ||
| Role of the fatty acid binding protein mal1 in obesity and insulin resistance | Q28587094 | ||
| Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice | Q33782682 | ||
| Liver fatty acid binding protein gene ablation potentiates hepatic cholesterol accumulation in cholesterol-fed female mice | Q34445819 | ||
| Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models | Q35625539 | ||
| Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships | Q35883220 | ||
| Biphasic expression of lipin suggests dual roles in adipocyte development | Q36064786 | ||
| The fatty liver and insulin resistance | Q36126652 | ||
| Mind the gap: analysis of marker-assisted breeding strategies for inbred mouse strains. | Q36441105 | ||
| Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice | Q38325289 | ||
| Liver fatty-acid-binding protein (L-FABP) gene ablation alters liver bile acid metabolism in male mice | Q39499094 | ||
| Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake | Q40969320 | ||
| PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance | Q43808960 | ||
| Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet | Q43908141 | ||
| Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. | Q43972538 | ||
| Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene | Q44387480 | ||
| Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance | Q44649369 | ||
| Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice | Q44680979 | ||
| The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance | Q44691209 | ||
| Liver fatty acid-binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes | Q44904775 | ||
| Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice. | Q44934606 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| fatty acid | Q61476 | ||
| knockout mouse | Q1364740 | ||
| steatosis | Q1365091 | ||
| P304 | page(s) | 1191-1205 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice | |
| P478 | volume | 44 |
| Q56987585 | A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects |
| Q28567584 | A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER |
| Q35796978 | Ablation of PI3K p110-α prevents high-fat diet-induced liver steatosis |
| Q37074304 | Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome |
| Q36960874 | Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models. |
| Q35800550 | Association of a Human FABP1 Gene Promoter Region Polymorphism with Altered Serum Triglyceride Levels |
| Q40720217 | Bovine serum albumin as the dominant form of dietary protein reduces subcutaneous fat mass, plasma leptin and plasma corticosterone in high fat-fed C57/BL6J mice |
| Q41585297 | Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion |
| Q46001740 | Cd36 knockout mice are protected against lithogenic diet-induced gallstones. |
| Q37334476 | Characterization of Colorectal Cancer Development in Apc (min/+) Mice |
| Q89619482 | Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus |
| Q35054010 | Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population |
| Q40230388 | Compared to casein, bovine lactoferrin reduces plasma leptin and corticosterone and affects hypothalamic gene expression without altering weight gain or fat mass in high fat diet fed C57/BL6J mice |
| Q33798621 | Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes |
| Q35839688 | Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice |
| Q34204377 | Deletion of Tis7 Protects Mice from High-Fat Diet-Induced Weight Gain and Blunts the Intestinal Adaptive Response Postresection |
| Q34418473 | Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice |
| Q46886591 | Diet-induced obesity and hepatic steatosis in L-Fabp / mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation |
| Q34979929 | Different functions of intestinal and liver-type fatty acid-binding proteins in intestine and in whole body energy homeostasis |
| Q37171953 | Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease |
| Q37234028 | Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding |
| Q33626557 | Disruption of retinoblastoma protein expression in the intestinal epithelium impairs lipid absorption |
| Q35561976 | Dissociation of diabetes and obesity in mice lacking orphan nuclear receptor small heterodimer partner |
| Q26996783 | Energy metabolism in the liver |
| Q35071134 | Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine |
| Q47788895 | FABP1 knockdown in human enterocytes impairs proliferation and alters lipid metabolism |
| Q53365082 | Fat and carbohydrate content in the diet induces drastic changes in gene expression in young Göttingen minipigs. |
| Q33613330 | Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias |
| Q28505425 | Fatty acid transport protein 4 is dispensable for intestinal lipid absorption in mice |
| Q33649348 | Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets |
| Q34589234 | Fenofibrate, a peroxisome proliferator-activated receptor α agonist, alters triglyceride metabolism in enterocytes of mice |
| Q24654808 | Forkhead box transcription factor O1 inhibits cholesterol 7alpha-hydroxylase in human hepatocytes and in high fat diet-fed mice |
| Q38301746 | Global transcriptome analysis of peripheral blood identifies the most significantly down-regulated genes associated with metabolism regulation in Klinefelter syndrome |
| Q37892758 | Gut-liver interaction in triglyceride-rich lipoprotein metabolism |
| Q37716343 | Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism |
| Q91480258 | Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor γ in Mice |
| Q90638448 | Hepatic Proteomic Changes and Sirt1/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis |
| Q35269224 | Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice |
| Q33771768 | Hepatic phenotype of liver fatty acid binding protein gene-ablated mice |
| Q36523963 | Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein |
| Q90698951 | Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveals distinct roles in fibrogenic injury |
| Q33701882 | High dietary fat exacerbates weight gain and obesity in female liver fatty acid binding protein gene-ablated mice |
| Q24650184 | Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism |
| Q93006421 | Increased Susceptibility to Obesity and Glucose Intolerance in Adult Female Rats Programmed by High-Protein Diet during Gestation, But Not during Lactation |
| Q37151863 | Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice |
| Q43251946 | Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. |
| Q36409227 | Inflammatory mechanisms in the regulation of insulin resistance |
| Q90213860 | Integrated mRNA and miRNA profile expression in livers of Jinhua and Landrace pigs |
| Q88453285 | Intestinal CD36 and Other Key Proteins of Lipid Utilization: Role in Absorption and Gut Homeostasis |
| Q33887747 | Knockdown of FABP5 mRNA decreases cellular cholesterol levels and results in decreased apoB100 secretion and triglyceride accumulation in ARPE-19 cells |
| Q39665840 | L-FABP T94A decreased fatty acid uptake and altered hepatic triglyceride and cholesterol accumulation in Chang liver cells stably transfected with L-FABP. |
| Q51471819 | L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. |
| Q34427355 | Lactase persistence and lipid pathway selection in the Maasai |
| Q36983184 | Laminin alpha 5 influences the architecture of the mouse small intestine mucosa |
| Q57843939 | Liver Fatty Acid-binding Protein Initiates Budding of Pre-chylomicron Transport Vesicles from Intestinal Endoplasmic Reticulum |
| Q36881286 | Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease |
| Q36808382 | Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice |
| Q37216923 | Liver fatty acid-binding protein (L-Fabp) modifies intestinal fatty acid composition and adenoma formation in ApcMin/+ mice |
| Q34120131 | Liver fatty acid-binding protein and obesity |
| Q64985867 | Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis. |
| Q39233272 | Liver metabolic disruption induced after a single exposure to PCB126 in rats |
| Q30443685 | Loss of Nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity |
| Q83601025 | Microarray analysis reveals the inhibition of intestinal expression of nutrient transporters in piglets infected with porcine epidemic diarrhea virus |
| Q30152626 | Molecular Dynamics Simulations of apo and holo forms of Fatty Acid Binding Protein 5 and Cellular Retinoic Acid Binding Protein II Reveal Highly Mobile Protein, Retinoic Acid Ligand, and Water Molecules. |
| Q30498009 | Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease) |
| Q37815214 | New insights from rodent models of fatty liver disease |
| Q58145237 | New mechanisms contributing to hepatic steatosis: glucose, insulin, and lipid signaling |
| Q26824738 | Nutritional modulation of insulin resistance |
| Q35294425 | Ostα-/- mice are not protected from western diet-induced weight gain |
| Q37629145 | Ostα-/- mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity. |
| Q27321622 | Over-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesity |
| Q36812508 | Pathogenesis and Prevention of Hepatic Steatosis |
| Q47215914 | Perilipin 5 and Liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells |
| Q36174516 | Phenotypic divergence in two lines of L-Fabp-/- mice reflects substrain differences and environmental modifiers |
| Q46457925 | Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice |
| Q35474502 | Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet. |
| Q33353210 | Proteomic analysis of fructose-induced fatty liver in hamsters |
| Q41328950 | Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. |
| Q28268205 | Recent insights into the biological functions of liver fatty acid binding protein 1 |
| Q33621757 | Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers |
| Q38289104 | Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice. |
| Q47266242 | Restoration of metabolic health by decreased consumption of branched-chain amino acids |
| Q36660888 | Role of the gut in lipid homeostasis |
| Q35192357 | Role of the gut in modulating lipoprotein metabolism. |
| Q28279093 | Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults |
| Q33862990 | Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease |
| Q36818022 | Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis |
| Q30373375 | Structural and functional analysis of fatty acid-binding proteins. |
| Q36754807 | Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver. |
| Q37798716 | Systemic effects of white adipose tissue dysregulation and obesity-related inflammation |
| Q90720544 | The Regulation of Lipokines by Environmental Factors |
| Q38410893 | The pathophysiology of intestinal lipoprotein production. |
| Q35913011 | Thioesterase superfamily member 2/acyl-CoA thioesterase 13 (Them2/Acot13) regulates hepatic lipid and glucose metabolism |
| Q30156061 | Tissue-specific functions in the fatty acid-binding protein family |
| Q47719467 | Triglyceride Metabolism in the Liver. |
| Q37669828 | Variation in genes related to hepatic lipid metabolism and changes in waist circumference and body weight |
Search more.